These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28778965)

  • 41. [Phosphocalcic metabolism: regulation and explorations].
    Courbebaisse M; Souberbielle JC
    Nephrol Ther; 2011 Apr; 7(2):118-38. PubMed ID: 21273150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The parathyroid is a target organ for FGF23 in rats.
    Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J
    J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrine functions of bone in mineral metabolism regulation.
    Quarles LD
    J Clin Invest; 2008 Dec; 118(12):3820-8. PubMed ID: 19033649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner.
    Murali SK; Roschger P; Zeitz U; Klaushofer K; Andrukhova O; Erben RG
    J Bone Miner Res; 2016 Jan; 31(1):129-42. PubMed ID: 26235988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
    Shimizu Y; Fukumoto S
    Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.
    Sitara D; Kim S; Razzaque MS; Bergwitz C; Taguchi T; Schüler C; Erben RG; Lanske B
    PLoS Genet; 2008 Aug; 4(8):e1000154. PubMed ID: 18688277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation.
    Yamashita H; Yamazaki Y; Hasegawa H; Yamashita T; Fukumoto S; Shigematsu T; Kazama JJ; Fukagawa M; Noguchi S
    Endocr J; 2007 Jun; 54(3):465-70. PubMed ID: 17464094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of fibroblast growth factor-23 in cardiorenal syndrome.
    Kovesdy CP; Quarles LD
    Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of phosphate in chronic kidney disease--Regulation of posphate homeostasis].
    Segawa H; Miyamoto K
    Clin Calcium; 2009 Feb; 19(2):159-65. PubMed ID: 19182353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overview of the FGF23-Klotho axis.
    Kuro-o M
    Pediatr Nephrol; 2010 Apr; 25(4):583-90. PubMed ID: 19626341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fibroblast growth factor-23 (FGF-23). Part I. Significance in phosphate homeostasis and bone metabolism].
    Fedak D; Bigaj K; Sułowicz W
    Przegl Lek; 2011; 68(4):231-8. PubMed ID: 21853680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FGF23 production by osteocytes.
    Bonewald LF; Wacker MJ
    Pediatr Nephrol; 2013 Apr; 28(4):563-8. PubMed ID: 22983423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [FGF23 and skeletal metabolism].
    Michigami T
    Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.